Cite
HARVARD Citation
McElvaney, N. et al. (2017). Long-term efficacy and safety of α1 proteinase inhibitor treatment for emphysema caused by severe α1 antitrypsin deficiency: an open-label extension trial (RAPID-OLE). Lancet. 5 (1), pp. 51-60. [Online].